ADCTCompensation•prnewswire•
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
Sentiment:Negative (20)
Summary
(NYSE:ADCT) LAUSANNE, Switzerland, Sept. 2, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that the Company has made grants of options to purchase an aggregate of 29,700 of the...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 2, 2025 by prnewswire